clinicAL CARDIOLOGY

IMAGE IN CARDIOVASCULAR MEDICINE

Cardiology Journal

2022, Vol. 29, No. 6, 1047–1048

DOI: 10.5603/CJ.2022.0112

Copyright © 2022 Via Medica

ISSN 1897–5593

eISSN 1898–018X

Cardiac imaging high-risk features of malignant mitral valve prolapse

María Anguita-GámezPablo ZuletFabián IslasJavier HiguerasCarmen Olmos
Instituto Cardiovascular, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdSSC), Madrid, Spain

Address for correspondence: María Anguita-Gámez, MD, Instituto Cardiovascular. Hospital Clínico San Carlos, Prof. Martín Lagos s/n, 28040 Madrid, Spain, tel: +34 913 303 149, fax: +34 913 303 290, e-mail: maria.anguita95@gmail.com

Received: 6.09.2022 Accepted: 13.10.2022

This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.

Mitral valve prolapse (MVP) is an underappreciated cause of sudden cardiac death (SCD). There are some imaging test signs that can help identify high-risk cases which may result in serious outcomes.

A 35-year-old woman suffered sudden loss of consciousness at home. Emergency services observed a ventricular fibrillation rhythm, and after the delivery of electric shocks, sinus rhythm returned, showing negative T waves in inferolateral leads (Fig. 1A). Two-dimensional echocardiogram showed prolapse and thickness of mitral leaflets and mitral annulus disjunction (separation of mitral leaflet and left atrial junction from left ventricular posterior wall during systole) (Fig. 1B). Doppler echocardiography showed tissue supranormal longitudinal strain in left ventricle posterolateral wall (Fig. 1C). Cardiac magnetic resonance (CMR) confirmed mitral annulus disjunction and showed pathological late gadolinium enhancement (LGE) in papillary muscles and inferolateral left ventricular wall (Fig. 1D, E). Pickelhaube sign (mitral annulus velocity > 16 cm/s) was also observed in the Doppler study (Fig. 1F). This sign is so called because of its similarity to an old Prussian soldiers’ helmet (Pickelhaube, in German) (Fig. 1G). Coronary artery disease was ruled out, and an implantable cardioverter-defibrillator was implanted. The substrate for ventricular arrhythmia is the presence of fibrosis, identified by LGE in CMR, in papillary muscles and inferobasal wall, due to an abnormal systolic mechanical stretch of the myocardium adjacent to the valve. Fortunately, most patients with these signs do not experience such a malignant course, but the finding of the described characteristics in MVP patients should alert us to the risk of SCD and lead to a careful monitoring and evaluation of the patients.

Figure 1. A. Baseline electrocardiogram in sinus rhythm, showing negative T waves in inferior and lateral leads; B. Two-dimensional echocardiogram (parasternal long-axis view), showing prolapse and thickness of both mitral leaflets and mitral annulus disjunction; C. Doppler echocardiography showing tissue supranormal longitudinal strain in left ventricle posterolateral wall; D, E. Cardiac magnetic resonance, showing pathological late gadolinium enhancement in papillary muscles and inferolateral left ventricular wall (D) and mitral annulus disjunction (E); F. Doppler study with the Pickelhaube sign (mitral annulus velocity > 16 cm/s), so called because of its similarity to an old Prussian soldiers’ helmet (Pickelhaube, in German) (G).
Conflict of interest: None declared

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl